Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Dalfo, E. (Esther) | - |
dc.creator | Rosa, J.L. (J.L.) | - |
dc.creator | Cuadrado-Tejedor, M. (Mar) | - |
dc.creator | Ambrosio, S. (S.) | - |
dc.date.accessioned | 2010-09-14T14:34:21Z | - |
dc.date.available | 2010-09-14T14:34:21Z | - |
dc.date.issued | 2004-04 | - |
dc.identifier.citation | Dalfo E, Gomez-Isla T, Rosa JL, Nieto Bodelon M, Cuadrado Tejedor M, Barrachina M, et al. Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice. J Neuropathol Exp Neurol 2004 Apr;63(4):302-313. | es_ES |
dc.identifier.isbn | 0022-3069 | - |
dc.identifier.uri | https://hdl.handle.net/10171/12341 | - |
dc.description.abstract | Mutation A30P in the alpha-synuclein gene is a cause of familial Parkinson disease. Transgenic mice expressing wild mouse and mutant human A30P alpha-synuclein, Tg5093 mice (Tg), show a progressive motor disorder characterized by tremor, rigidity, and dystonia, accompanied by accumulation of alpha-synuclein in the soma and neurites and by a conspicuous gliosis beginning in the hippocampal formation at the age of 7 to 8 months and spreading throughout the CNS. Impaired short-term changes in synaptic strength have also been documented in hippocampal slices from Tg mice. Alpha-synuclein aggregates of approximately 34 and 70 kDa, in addition to the band of 17 kDa, corresponding to the molecular weight of alpha-synuclein, were recovered in the PBS-soluble fraction of brain homogenates from Tg mice but not from brain samples from age-matched wildtype littermates. MPTP-treated Tg and wildtype mice produced alpha-synuclein aggregates in the PBS-, deoxycholate-, and SDS-soluble fractions. Aggregates of alpha-synuclein, although with different molecular weights, were also observed in rotenone-treated Tg and wildtype mice. Pull-down studies with members of the Rab protein family have shown that alpha-synuclein from Tg mice interacts with Rab3a, Rab5, and Rab8. This binding is not due to the amount of alpha-synuclein (levels of which are higher in Tg mice) and it is not dependent on the amount of Rab protein used in the assay. Rather, alpha-synuclein interactions with Rab proteins are due to mutant alpha-synuclein as demonstrated in Rab pull-down assays with recombinant of wildtype and mutant A30P human alpha-synuclein. Since Rab3a, Rab5, and Rab8 are important proteins involved in synaptic vesicle trafficking and exocytosis at the synapse, vesicle endocytosis, and trans-Golgi transport, respectively, it can be suggested that these functions are impaired in Tg mice. This rationale is consistent with previous data showing that short-term hippocampal synaptic plasticity is altered and that alpha-synuclein accumulates in the cytoplasm of neurons in Tg mice. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | es_ES |
dc.rights | info:eu-repo/semantics/closedAccess | - |
dc.subject | Parkinson | es_ES |
dc.title | Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
articulos.autor.creador | Gómez-Isla T | - |
articulos.autor.creador | Nieto Bodelón | - |
articulos.autor.creador | Barrachina M | - |
dc.relation.publisherversion | http://journals.lww.com/jneuropath/pages/articleviewer.aspx?year=2004&issue=04000&article=00003&type=abstract | - |
Files in This Item:
There are no files associated with this item.
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.